have nine new products to be launched in 2010”
—Hemant K Gupta,
president, Axygen Scientific
Founded and incorporated
in 1993, Axygen Scientific is one of the leading global suppliers of
laboratory plastics for the research industry, including the
pharmaceutical, biotech, and academia markets. Axygen is headquartered
in Union City, California. In an interview with Hemant K
Gupta, president, Axygen Scientific, we find out more about the
company’s future plans.
been the company’s revenues for the year 2008-2009? What
percentage of these are derived from the Asia Pacific region?
We registered consolidated revenues of $110 million
in 2008, including the 80 countries that Axygen
operates in. Approximately 5.2 percent of our revenues are derived from
the Asia Pacific region. We have been meeting our targets every year
and this year also we expect similar performance. Some of the growth
drivers of Axygen are the constant introduction of new products,
penetration of international markets and strategic acquisitions.
How has Axygen
addressed the needs of the life sciences market since its inception?
For Axygen product improvement does not stop with a one-time change.
It’s a continuous process driven by our desire to help
scientists to get consistent results faster and easier. Our
R&D, engineering and marketing teams work closely with
customers to continuously update our products and introduce novel
What are the
different segments that the company operates in and what are the
revenue grossing products for Axygen over the last year?
High throughput screening (HTS), PCR and reagents are some of the
segments we operate in. We enjoy a market share of 60 percent in the
HTS segment in India.
High throughput screening products have been the biggest revenue driver
for Axygen over the last year. Recently we have entered into the
nucleic acid purification market with a wide range of kits and reagents.
What are the major
collaborations of Axygen over the last year and how those
collaborations influenced the business?
We have a number of important collaborations with the academia and
industry. We have become a leader in our market by strategic
acquisitions of other companies. Including the
recently acquired Sorenson Biosciences (2008), a global
leader in innovative consumables and lab-ware.
What are the emerging
markets for Axygen and how are you trying to increase the business in
China, India and
Singapore are some of the emerging markets for Axygen.
Our field staffs are working closely with our distribution partners to
identify opportunities and close them in a timely fashion. We have also
organized training programs and sales meetings to bring our
distributors closer to us and penetrate the market.
What do you think is
the strength of the company?
We believe our strength is in our field personnel who work with our
customers. We also have a strong marketing team in all the countries
that we operate in. We believe we are a customer-friendly company that
involves the scientist in building up our product range. Besides, we
can design and manufacture consumable products and kits from any of our
What are the trends
that you see in technology worldwide?
Customers are looking for the freedom to choose their robotic system
and have consumables to work with the system of their choice. Customers
don’t want to be locked in with a single company for
instruments and consumables which limits their choices. We offer
consumables that work on a number of market leading platforms and give
customers the power to choose. Customers are also looking for the best
value for their money and Axygen can deliver this for the customers.
What are the products
to be launched next year?
Two technologies that we plan to launch in the coming year are RNA and
micro RNA isolation kits for RNAi and stem cell research and novel
reagents like X-Gal/IPTG spray and Smart Ampicillin. This year, we plan
to launch cell and tissue culture lab-ware. In the first half of the
year we plan to launch protein kits and protein matrix in the Indian
market. We have nine new products to be launched in 2010 in the area of
HTS, five new products in the reagents segment. We also aim to go a
notch up and register a 10 percent increase in revenues in the next
financial year through our product range.